Publication | Closed Access

Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation

Hematological MalignancyHematologyMyeloid NeoplasiaTechnetium-99m-sestamibi ScintigraphyHigh-dose ChemotherapyActive Myeloma LesionsOncologyRadiation OncologyNuclear MedicineRadiologyHealth Sciences